Thesis (doctoral)--Freie Universität Berlin, 1979.

Thesis supervisor: Elaine M. Smith. Includes bibliographic references (p. 187-222).

Thesis (Doctoral-Genetics)--Universiteit te Utrecht. / "Literatuur": p. 92-96.

Thesis (Ph. D.)--University of Michigan.

Thesis (J.C.L.)--Catholic University of America, 1985. / Typescript. Includes bibliographical references (leaves 54-56).

Thesis (M.A.)--Reformed Theological Seminary, 1985. / Includes bibliographical references (leaves 68-72).

This essay examines nationalist party views on abortion. The abortion policies of the Sweden Democrats, the United Kingdom Independence Party, and Sinn Féin are studied through descriptive actor-centred idea analysis. Utilising theories on nationalism and abortion policy, the party policies on abortion are scrutinised in terms of which conception of abortion they subscribe to, and how actors and objects in relation to abortion are perceived. Subsequently these views are compared, showing a great overlap in terms of how abortion as a public issue is conceived, and how the objects and actors involved are perceived. All parties in the study subscribe to a moral conception of abortion to some extent, and the aborting woman and the foetus become the main focal points. In other regards party policies on abortion vary greatly.

Despite the decriminalization of abortion in Canada in 1988, women still face many barriers to abortion care. With the registration of Mifegymiso® (mifepristone, or RU486) in Canada in July 2015, there is hope that the gold-standard medication abortion could alleviate some of those barriers women face. In this thesis, I used data from a Canada-wide study exploring women’s abortion experiences by way of in-depth interviews to investigate mifepristone’s potential to alter the abortion care landscape. My thesis is comprised of two articles: one using selections from 174 interviews across five provinces, the other using 13 full interviews from Newfoundland as a case study. These papers suggest that women would be interested in using mifepristone once available in Canada, and identified both benefits of and concerns about this method of early pregnancy termination. Despite many unanswered questions as to how and when Mifegymiso® will become available, the registration of this important abortifacient has the promise to increase access and expand choice for Canadian women. Malgré la décriminalisation de l’avortement en 1988, les femmes font toujours face à des obstacles de soins. Avec l'enregistrement de Mifegymiso® (mifépristone, ou RU-486) au Canada en Juillet 2015, il y a espoir que ce médicament d’avortement pourrait atténuer certains de ces obstacles auxquels les femmes sont confrontées. Dans cette thèse, j'ai utilisé les données d'une étude qui explore les expériences d’avortements des femmes à travers le Canada. Les données ont été récupérer par moyen d’entrevues en profondeur et enquête le potentiel du médicament mifépristone à améliorer le paysage de soins de l’avortement. Ma thèse est composée de deux articles: la première inclue une sélection parmi 174 entrevues dans cinq provinces et la deuxième inclus 13 entrevues comme étude de cas de la province de Terre-Neuve. Ces articles suggèrent que l'intérêt pour la mifépristone pourrait être élevé au Canada après l'intégration de ce médicament, et les femmes perçoivent plusieurs avantages à cette méthode de terminaison prématurée de la grossesse et que les femmes ont certaines préoccupations. Malgré qu'il y ait beaucoup de questions sans réponse quant à la façon et quand Mifegymiso® sera disponible, l'enregistrement de cet important abortif a la promesse d'accroître l'accès et élargir le choix pour les femmes canadiennes.

Abortion upon request has been legal in Turkey since 1983. In 2012 the Prime Minister of Turkey announced his intent to restrict or ban abortion. The public protested in response and the Turkish government did not amend the abortion law. However, recent anecdotal evidence suggests that the provision of abortion in public hospitals has diminished significantly. The purpose of this qualitative study was to explore women’s experiences obtaining abortion care in Istanbul, Turkey. We also documented key informants’ perspectives about abortion and reproductive health service availability in Istanbul. According to women and key informants, abortion availability has decreased remarkably and is now only available in one public hospital in Istanbul. Abortion care remains available in the private sector but there are nonetheless barriers to obtaining timely abortion care in Turkey. To improve abortion services, future efforts should focus on re-integrating abortion services in the public sector and making medication abortion available to Turkish women.

No description available.